Nuriye Ezgi Bektur Aykanat

Nuriye Ezgi Bektur Aykanat

Auto-generated profile, based on publicly available information

Nuriye Ezgi Bektur Aykanat

Atılım Üniversitesi Tıp Fakültesi, Histoloji ve Embriyoloji Anabilim Dalı, Ankara

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
ESErhan Sahin
Erhan Sahin
RBRidvan Bagci
Ridvan Bagci
NANuriye Ezgi Bektur Aykanat
Nuriye Ezgi Bektur Aykanat
SKSedat Kacar
Sedat Kacar
VSVarol Sahinturk
Varol Sahinturk

8 January 2020 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
NANuriye Ezgi Bektur Aykanat
Nuriye Ezgi Bektur Aykanat
SKSedat Kacar
Sedat Kacar
SKSerife Karakaya
Serife Karakaya
VSVarol Sahinturk
Varol Sahinturk

15 February 2020 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SKSedat Kacar
Sedat Kacar
NANuriye Ezgi Bektur Aykanat
Nuriye Ezgi Bektur Aykanat
VSVarol Sahinturk
Varol Sahinturk

13 February 2019 in Neurological Research
Verified
Journal Article
Closed access
EBEzgi Bektur
Ezgi Bektur
EŞErhan Şahin
Erhan Şahin
ECEmre Ceyhan
Emre Ceyhan
DDDilek Burukoglu Donmez
Dilek Burukoglu Donmez
MCMediha Canbek
Mediha Canbek
OCOzgur Devrim Can
Ozgur Devrim Can
Objectives: Neuropathic pain reduces the life qualities of patients with Diabetes mellitus. Clinical guidelines recommend relief in diabetic neuropathic pain through the use of some antidepressants, anticonvulsants, opioids as well as capsaicin cream or lidocaine patches. However, since the majority of patients do not or partially respond to current treatments, there is a growing necessity for new drugs increasing the pain relief in patients with diabetes. Therefore, based on the therapeutic potential of antidepressants on neuropathic pain, we investigated the promising antihyperalgesic effect of mirtazapine (MRT) in painful diabetic neuropathy. Methods: Experimental diabetes was induced in rats by single intraperitoneal injection of 55 mg/kg dose of streptozocin (STZ). After 4 weeks of injection of STZ, MRT was administrated for 14 days at 40 mg/kg dose. Randall–Selitto and Hargreaves tests were applied for paw-withdrawal threshold and paw-withdrawal latency measurement. TRPV1 and ASIC1 expressions measured by Western blot in dorsal root ganglion and spinal cord. Results: Administration of MRT significantly improved both of the decreased paw-withdrawal threshold and shortened the paw-withdrawal latency of diabetic rats, respectively. Besides, increased levels of TRPV1 and ASIC1 channels in dorsal root ganglion and spinal cord of diabetic rats, evaluated by Western blot method, were decreased following the MRT treatment. Discussion: These data show, for the first time, that MRT has beneficial effects against diabetes-induced hyperalgesia, and that suppressive effect of this drug on TRPV1 and ASIC1 levels, which are increased in diabetic rats, may be some of the pharmacological mechanisms underlying the exhibited antihyperalgesic effect of MRT.

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
MKMuhammed Kandemi̇r
Muhammed Kandemi̇r
NYNecdet Yaşar
Necdet Yaşar
MÖMete Özkurt
Mete Özkurt
RÖRumeysa Özyurt
Rumeysa Özyurt
NANuriye Ezgi Bektur Aykanat
Nuriye Ezgi Bektur Aykanat
NENilüfer Erkasap
Nilüfer Erkasap
Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into four groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50mg/kg and 100mg/kg, respectively). Gene expressions of Caspase-3, TNF-?, IL-1?, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of SOD, CAT, and MDA were studied by the ELISA method and tissue samples were examined histopathologically as well. Anakinra inhibited the expression of IL-1?, IL-6, and TNF-? and decreased the SOD, CAT, and MDA caused by ischemia-reperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups as well were less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100mg/kg was found to be histopathologically more effective.

28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
NANuriye Ezgi Bektur Aykanat
Nuriye Ezgi Bektur Aykanat
ESErhan Sahin
Erhan Sahin
SKSedat Kacar
Sedat Kacar
RBRıdvan Bağci
Rıdvan Bağci
ŞKŞerife Karakaya
Şerife Karakaya
VSVarol Sahinturk
Varol Sahinturk
Background/aim: Hyperthyroidism is associated with results in increased glomerular filtration rate as well as increased renin-angiotensin-aldosterone activation. The disturbance of Ca2+ homeostasis in the endoplasmic reticulum (ER) is associated with many diseases, including diabetic nephropathy and hyperthyroidism. Transient receptor potential canonical 1 (TRPC1) channel is the first cloned TRPC family protein. Although it is expressed in many places in the kidney, its function is uncertain. TRPC1 is involved in regulating Ca2+ homeostasis, and its upregulation increases ER Ca2+ level, activates the unfolded protein response, which leads to cellular damage in the kidney. This study investigated the role of TRPC1 in the kidneys of hyperthyroid rats in terms of ER stress markers that are glucose-regulated protein 78 (GRP78), activating transcription factor 6 (ATF6), (protein kinase R (PKR)-like endoplasmic reticulum kinase) (PERK), Inositol-requiring enzyme 1 (IRE1). Materials and methods: Twenty male rats were assigned into control and hyperthyroid groups (n = 10). Hyperthyroidism was induced by adding 12 mg/L thyroxine into the drinking water of rats for 4 weeks. The serum-free T3 and T4 (fT3, fT4), TSH, blood urea nitrogen (BUN), and creatinine levels were measured. The histochemical analysis of kidney sections for morphological changes and also immunohistochemical and western blot analysis of kidney sections were performed for GRP78, ATF6, PERK, IRE1, TRPC1 antibodies. Results: TSH, BUN, and creatinine levels decreased while fT3 and fT4 levels increased in the hyperthyroid rat. The morphologic analysis resulted in the capillary basal membrane thickening in glomeruli and also western blot, and immunohistochemical results showed an increase in TRPC1, GRP78, and ATF6 in the hyperthyroid rat (p < 0.05). Conclusion: In conclusion, in our study, we showed for the first time that the relationship between ER stress and TRPC1, and their increased expression caused renal damage in hyperthyroid rats.